Test
200 articles
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.
Changing My Life for the Better
Robin Schroeder was an avid runner before her pancreatic neuroendocrine tumor diagnosis. Now she’s back competing in half-marathons.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Crafting a Medical Family Tree
Dr. Diane Simeone and genetic counselor Jessica Everett explain why it is important to create a medical family tree for pancreatic cancer.
The Relationship Between Diabetes and Pancreatic Cancer
Whether you have type 1 or type 2 diabetes you are at an increased risk for developing pancreatic cancer. Learn more about your risk by reading this story.
Chemotherapy Regimen for Post-Surgery PNET Patients
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
Pancreatic Cancer Organizations Join in Mourning Aretha Franklin
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
The Promise of Organoids
Dr. Brian Wolpin explains how organoids are being used to develop personalized treatment for pancreatic cancer patients.
Predicting Effective Therapy in Pancreatic Cancer
Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Testing a Thyroid Cancer Drug to Treat Advanced Pancreatic Neuroendocrine Tumors
Researchers are testing a thyroid drug to see if it is effective against pancreatic neuroendocrine tumors, among other cancers.